Mineralys Therapeutics welcomes Dr. Alex Gold to its Board of Directors

– USA, PA –  Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease, and other diseases driven by dysregulated aldosterone, announced the appointment of Dr.

Alzheon adds Gino Santini to its Board of Directors

– USA, MA –  Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s disease (AD) and other neurodegenerative disorders, announced the appointment of Gino Santini to its Board of Directors.…

BPGbio welcomes Scott Minick to its Board of Directors

– USA, MA –  BPGbio, Inc., a leading biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, announced the election of Scott Minick to its Board of Directors to advise the executive team in the next phase of commercialization and partnering transactions using its NAi Interrogative Biology Platform.…